- Coordinator
- The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin, Ireland
- Runs
- 1 November 2026 to 31 October 2031
- Status
- Running
- EU funding
- €1.7m
- Total cost
- €1.7m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101300802
What the project is doing
In the project's own words, from its summary on CORDIS.
RNA viruses, including Zika, SARS-CoV-2, and Hepatitis C, impose a profound global health burden, causing millions of deaths every year. The extraordinary rates of mutations and chemical modifications in these RNA-based pathogens enable rapid adaptation and, ultimately, immune evasion. Current detection technologies fail to capture the molecular heterogeneity that drives viral evolution, relying on ensemble averaging, biased enzymatic amplification, or computational inference to compensate for low signal-to-noise.
SNAPRR aims to overcome these limitations by developing a unified single-molecule platform that identifies viral RNAs and their underlying mutations, and chemical modifications, revealing the hidden chemical diversity that shapes infectivity and pathogenesis. SNAPRR harnesses three emerging technologies to sensitively and specifically probe viral RNA chemistry. 1) Solid-state nanopores translate individual RNA molecules into recognisable ionic current signatures, enabling rapid, quantitative readout. 2) Programmable nucleic acid nanotechnology uniquely barcodes viral RNAs for multiplexed detection, and 3) Chemoselective labelling amplifies signals from single-nucleotide mutations and chemical modifications for direct nanopore localisation.
By revealing strand-to-strand heterogeneity, SNAPRR will redefine our understanding of RNA virus biology, inform next-generation diagnostics, and provide a versatile framework for antiviral development and RNA vaccine quality control. Bridging chemistry, nanotechnology, and biophysics, this project combines fundamental insight with practical impact, creating a portable, amplification-free approach to tackle the global challenge of rapidly evolving RNA viruses.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin | Dublin | Ireland | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI